Cefdinir: An oral alternative to parenteral cephems

Diagnostic Microbiology and Infectious Disease

Volumn 51, Issue 4, 2005, Pages 259-264

  Chatterjee, Archana ^a   Moland, Ellen S ^b   Thomson, Kenneth S ^b  

^a CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

^b CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cefdinir; Common pathogens; Parenteral cephems

Indexed keywords

BETA LACTAMASE; CEFAZOLIN; CEFDINIR; CEFEPIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE;

ARTICLE; DRUG ACTIVITY; DRUG POTENCY; HAEMOPHILUS INFLUENZAE; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MORAXELLA CATARRHALIS; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

EID: 16244394038     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2004.11.015     Document Type: Article

References (21)

1. S.T. Chambers, D.R. Murdoch, and M.J. Pearce Clinical and economic considerations in the use of third-generation oral cephalosporins Pharmacoeconomics 7 1995 416 427
2. D.R. Guay Pharmacodynamics and pharmacokinetics of cefdinir, an oral extended spectrum cephalosporin Pediatr. Infect. Dis. J. 19 12, Suppl. 2000 S141 S146
3. D.R. Guay Cefdinir: an advanced-generation, broad-spectrum oral cephalosporin Clin. Ther. 24 2002 473 489
4. D.R. Guay Cefdinir: an expanded-spectrum oral cephalosporin Ann. Pharmacother. 34 2002 1469 1477
5. D.M. Johnson, H.S. Sader, T.R. Fritsche, D.J. Biedenbach, and R.N. Jones Susceptibility trends of Haemophilus influenzae and Moraxella catarrhalis against orally administered antimicrobial agents: five-year report from the SENTRY Antimicrobial Surveillance Program Diagn. Microbiol. Infect. Dis. 47 2003 373 376
6. S. Knowles, L. Shapiro, and N. Shear Reactive metabolites and adverse drug reactions: clinical considerations Clin. Rev. Allergy Immunol. 24 2003 229 238
7. A.P. Leigh, M.A. Nemeth, C.H. Keyserling, L.H. Hotary, and K.J. Tack Cefdinir versus cefaclor in the treatment of uncomplicated urinary tract infection Clin. Ther. 22 2000 818 825
8. National Committee for Clinical Laboratory Standards Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically-fifth edition: approved standard NCCLS document M7-A5 2000 NCCLS Wayne (Pa)
9. M.A. Nemeth, W.M. Gooch, J. Hedrick, E. Slosberg, C.H. Keyserling, and K.J. Tack Comparison of cefdinir and penicillin for the treatment of pediatric streptococcal pharyngitis Clin. Ther. 21 1999 1525 1532
10. D.J. Payne, and S.G. Amyes Stability of cefdinir (C1-983, FK482) to extended spectrum plasmid-mediated beta-lactamases J. Med. Microbiol. 38 1993 114 117
11. C. Pena, M. Pujol, C. Ardunay, A. Ricart, and F. Gudiol Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases Antimicrob. Agents Chemother. 42 1998 53 58
12. M. Peric, F.A. Browne, M.R. Jacobs, and P.C. Appelbaum Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of β-lactam and macrolide antimicrobial agents Clin. Ther. 25 2003 169 177
13. J.L. Powers, W.M. Gooch, and L.P. Oddo Comparison of the palatability of the oral suspension of cefdinir vs. amoxicillin/clavulanate potassium, cefprozil and azithromycin in pediatric patients Pediatr. Infect. Dis. J. 19 12, Suppl. 2000 S174 S180
14. R.W. Steele, M.P. Thomas, and R.E. Begue Compliance issues related to the selection of antibiotic suspensions for children Pediatr. Infect. Dis. J. 20 2001 1 5
15. M. Steurer, and P. Schenk Efficacy and safety of cefdinir in the treatment of maxillary sinusitis Eur. Arch. Otorhinolaryngol. 257 2000 140 148
16. K.J. Tack, D.C. Henry, W.M. Gooch, D.N. Brink, and C.H. Keyserling Five day cefdinir treatment for streptococcal pharyngitis. Cefdinir Pharyngitis Study Group Antimicrob. Agents Chemother. 42 1998 1073 1075
17. K.J. Tack, T.W. Littlejohn, G. Mailloux, M.M. Wolf, and C.H. Keyserling Cefdinir versus cephalexin for the treatment of skin and skin-structure infections. The Cefdinir Adult Skin Infection Study Group Clin. Ther. 20 1998 244 256
18. Cefdinir-a new oral cephalosporin Med. Lett. Drugs Ther. 40 1998 85 87
19. C.L. Van-Herwaarden, C.E. Langan, G. Siemon, C. Rudolph, C.H. Keyserling, M.A. Nemeth, and K.J. Tack International study comparing cefdinir and cefuroxime axetil in the treatment of patients with acute exacerbation of chronic bronchitis Int. J. Infect. Dis. 4 2000 26 33
20. J. Verhaegen, and L. Verbist Oral cephalosporins Acta Clin. Belg. 47 1992 377 386
21. J. Yerushalmi, A. Zvulunov, and S. Halevy Serum-sickness-like reactions Cutis 69 2002 395 397